ABEONA THERAPEUTICS INC
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
ABEO$2.46-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sale of Equity Securities and Use of Proceeds
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
(c) The following table provides information about purchases of equity securities that are registered pursuant to Section 12 of the Exchange Act for the quarter ended September 30, 2024:
| Total number of shares (or units) purchased (a) | Average price paid per share (or unit) | |
|---|---|---|
| Shares delivered or withheld pursuant to restricted stock awards | ||
| July 1, 2024 - July 31, 2024 | 1,055 | $$5.11 |
| August 1, 2024 - August 31, 2024 | — | $— |
| September 1, 2024 - September 30, 2024 | 32,261 | $$5.89 |
| 33,316 | $$5.87 | |
| (a) | Reflects shares of common stock surrendered to the Company for payment of tax withholding obligations in connection with the vesting of restricted stock. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.